Enantiopure titanocene complexes: direct evidence for paraptosis in cancer cells

Tolerated by normal tissues, anti-cancer therapies based on titanium compounds are limited by low efficacy/selectivity and lack of understanding of their mode(s) of action. In vitro antitumour activity and mode of cell death incurred by enantiopure TiCl2{n-C5H4CHEt(2 MeOPh)}2 (abbreviated CpR 2TiCl2...

Full description

Bibliographic Details
Main Authors: Cini, Melchior, Williams, Huw Edward Llewelyn, Fay, Mike W., Searle, Mark, Woodward, Simon, Bradshaw, Tracey D.
Format: Article
Published: Royal Society of Chemistry 2016
Subjects:
Online Access:https://eprints.nottingham.ac.uk/31374/
_version_ 1848794186799644672
author Cini, Melchior
Williams, Huw Edward Llewelyn
Fay, Mike W.
Searle, Mark
Woodward, Simon
Bradshaw, Tracey D.
author_facet Cini, Melchior
Williams, Huw Edward Llewelyn
Fay, Mike W.
Searle, Mark
Woodward, Simon
Bradshaw, Tracey D.
author_sort Cini, Melchior
building Nottingham Research Data Repository
collection Online Access
description Tolerated by normal tissues, anti-cancer therapies based on titanium compounds are limited by low efficacy/selectivity and lack of understanding of their mode(s) of action. In vitro antitumour activity and mode of cell death incurred by enantiopure TiCl2{n-C5H4CHEt(2 MeOPh)}2 (abbreviated CpR 2TiCl2) has been investigated. The in vitro anti-tumour activity of CpR 2TiCl2 is selective for cancer cells; in clonogenic assays, (S,S)-CpR 2TiCl2 was twice as effective at inhibiting colony formation than other stereoisomers after 24 h exposure. HPLC, MS and NMR techniques determined hydrolysis of CpR 2TiCl2; data strongly correlate with soluble [CpR 2Ti(OH (OH2)]+ being the biological trigger. Treatment of cells with CpR 2TiCl2 provoked extensive cytoplasmic vacuolization, endoplasmic reticulum (ER) swelling and activation of MAPKinase signal transduction, consistent with ligand-induced paraptosis, type III cell death, which is morphologically distinct from, and independent of apoptosis. Indeed, distinct from cisplatin, CpR 2TiCl2 failed to perturb cell cycle dynamics, induce γH2AX foci or evoke apoptosis in MDA-MB-468 and HCT-116 cells.
first_indexed 2025-11-14T19:12:12Z
format Article
id nottingham-31374
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:12:12Z
publishDate 2016
publisher Royal Society of Chemistry
recordtype eprints
repository_type Digital Repository
spelling nottingham-313742020-05-04T17:31:37Z https://eprints.nottingham.ac.uk/31374/ Enantiopure titanocene complexes: direct evidence for paraptosis in cancer cells Cini, Melchior Williams, Huw Edward Llewelyn Fay, Mike W. Searle, Mark Woodward, Simon Bradshaw, Tracey D. Tolerated by normal tissues, anti-cancer therapies based on titanium compounds are limited by low efficacy/selectivity and lack of understanding of their mode(s) of action. In vitro antitumour activity and mode of cell death incurred by enantiopure TiCl2{n-C5H4CHEt(2 MeOPh)}2 (abbreviated CpR 2TiCl2) has been investigated. The in vitro anti-tumour activity of CpR 2TiCl2 is selective for cancer cells; in clonogenic assays, (S,S)-CpR 2TiCl2 was twice as effective at inhibiting colony formation than other stereoisomers after 24 h exposure. HPLC, MS and NMR techniques determined hydrolysis of CpR 2TiCl2; data strongly correlate with soluble [CpR 2Ti(OH (OH2)]+ being the biological trigger. Treatment of cells with CpR 2TiCl2 provoked extensive cytoplasmic vacuolization, endoplasmic reticulum (ER) swelling and activation of MAPKinase signal transduction, consistent with ligand-induced paraptosis, type III cell death, which is morphologically distinct from, and independent of apoptosis. Indeed, distinct from cisplatin, CpR 2TiCl2 failed to perturb cell cycle dynamics, induce γH2AX foci or evoke apoptosis in MDA-MB-468 and HCT-116 cells. Royal Society of Chemistry 2016-01-18 Article PeerReviewed Cini, Melchior, Williams, Huw Edward Llewelyn, Fay, Mike W., Searle, Mark, Woodward, Simon and Bradshaw, Tracey D. (2016) Enantiopure titanocene complexes: direct evidence for paraptosis in cancer cells. Metallomics . ISSN 1756-591X Titanocenes chiral cyclopentadienyls paraptosis cancer http://pubs.rsc.org/en/Content/ArticleLanding/2016/MT/C5MT00297D#!divAbstract doi:10.1039/C5MT00297D doi:10.1039/C5MT00297D
spellingShingle Titanocenes
chiral cyclopentadienyls
paraptosis
cancer
Cini, Melchior
Williams, Huw Edward Llewelyn
Fay, Mike W.
Searle, Mark
Woodward, Simon
Bradshaw, Tracey D.
Enantiopure titanocene complexes: direct evidence for paraptosis in cancer cells
title Enantiopure titanocene complexes: direct evidence for paraptosis in cancer cells
title_full Enantiopure titanocene complexes: direct evidence for paraptosis in cancer cells
title_fullStr Enantiopure titanocene complexes: direct evidence for paraptosis in cancer cells
title_full_unstemmed Enantiopure titanocene complexes: direct evidence for paraptosis in cancer cells
title_short Enantiopure titanocene complexes: direct evidence for paraptosis in cancer cells
title_sort enantiopure titanocene complexes: direct evidence for paraptosis in cancer cells
topic Titanocenes
chiral cyclopentadienyls
paraptosis
cancer
url https://eprints.nottingham.ac.uk/31374/
https://eprints.nottingham.ac.uk/31374/
https://eprints.nottingham.ac.uk/31374/